Cerus Corporation (CERS)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Blood Safety	206.13M	180.27M	156.37M	162.05M	130.86M
Blood Safety Growth	14.35%	15.29%	-3.51%	23.83%	42.36%
Total	206.13M	180.27M	156.37M	162.05M	130.86M
Total Growth	14.35%	15.29%	-3.51%	23.83%	42.36%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Other Countries	60.21M	51.32M	44.65M	41.33M	42.47M
Other Countries Growth	17.32%	14.96%	8.02%	-2.69%	3.60%
United States	124.72M	109.26M	93.23M	101.39M	67.50M
United States Growth	14.16%	17.19%	-8.05%	50.21%	114.16%
France	21.20M	19.69M	18.49M	19.33M	20.89M
France Growth	7.65%	6.50%	-4.33%	-7.47%	7.64%
Total	206.13M	180.27M	156.37M	162.05M	130.86M
Total Growth	14.35%	15.29%	-3.51%	23.83%	42.36%

Data Source: S&P Global Market Intelligence Last updated: Apr 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 26, 2026

Data Sources Report a data error